Antonino Amato
Chief Executive Officer at PinCell Srl
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Carlo Pincelli | M | - |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | 16 years |
Alessandra Marconi | M | - |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | 16 years |
Carlo dell'Aringa | M | 83 |
Università Cattolica del Sacro Cuore Campus di Milano
| 42 years |
Luigi Costa | M | 59 |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | 4 years |
Paola Pozzi | F | - |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sabrina di Bartolomeo | F | 52 |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | 3 years |
Maria Gabriella Camboni | M | 66 |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | 2 years |
Andrea Montevecchi | M | - |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | - |
Trevor Jones | M | 82 |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | - |
Massimo Folador | M | 63 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Patrizia de Marchi | F | 64 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Roberto Moro Visconti | M | - |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Fabio Ceccarelli | M | - |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Giovanni Raimondi | M | 65 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Gabriele Verganti | M | 66 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Maria Leddi | F | 70 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Antonio Maria Penna | M | - |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Laura Rovizzi | F | 60 |
Università Cattolica del Sacro Cuore Campus di Milano
| 5 years |
Daniela Ciccardi | F | 64 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Maurizio Bonzi | M | 63 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Patrizia Arienti | F | - |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Marco Brughera | M | 70 |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | 1 years |
Manuela Soffientini | F | 64 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Massimo Piombini | M | - |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Franco Confalonieri | M | 60 |
Università Cattolica del Sacro Cuore Campus di Milano
| 6 years |
Mario Anolli | M | 61 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Ugo di Francesco | M | 63 |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | 4 years |
Franco Novelli | M | 67 |
Università Cattolica del Sacro Cuore Campus di Milano
| 3 years |
Giuseppe Gianoglio | M | - |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Franco Dalla Sega | M | 64 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Marco Maria Fumagalli | M | 62 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Massimo Maria Cremona | M | 65 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Marco Andreasi | M | 64 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Marco Fortis | M | 68 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Massimo Belcredi | M | 62 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Marco Roberto Cabassi | M | 63 |
Università Cattolica del Sacro Cuore Campus di Milano
| 4 years |
Giovanni Francesco Lega | M | 67 |
Università Cattolica del Sacro Cuore Campus di Milano
| 3 years |
Damiano Zazzeron | M | - |
Università Cattolica del Sacro Cuore Campus di Milano
| 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
Italy | 38 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Antonino Amato
- Personal Network